AVITA Medical Inc (RCEL)
8.77
+0.12
(+1.39%)
USD |
NASDAQ |
May 02, 12:34
AVITA Medical Enterprise Value: 173.12M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 01, 2024 | 173.12M |
April 30, 2024 | 166.69M |
April 29, 2024 | 174.92M |
April 26, 2024 | 169.78M |
April 25, 2024 | 164.12M |
April 24, 2024 | 171.06M |
April 23, 2024 | 181.60M |
April 22, 2024 | 170.55M |
April 19, 2024 | 172.86M |
April 18, 2024 | 178.77M |
April 17, 2024 | 191.88M |
April 16, 2024 | 200.11M |
April 15, 2024 | 193.94M |
April 12, 2024 | 204.74M |
April 11, 2024 | 216.82M |
April 10, 2024 | 321.96M |
April 09, 2024 | 335.58M |
April 08, 2024 | 339.70M |
April 05, 2024 | 346.38M |
April 04, 2024 | 339.44M |
April 03, 2024 | 339.95M |
April 02, 2024 | 342.01M |
April 01, 2024 | 350.49M |
March 28, 2024 | 362.83M |
March 27, 2024 | 374.92M |
Date | Value |
---|---|
March 26, 2024 | 361.81M |
March 25, 2024 | 358.59M |
March 22, 2024 | 354.09M |
March 21, 2024 | 365.40M |
March 20, 2024 | 365.92M |
March 19, 2024 | 363.09M |
March 18, 2024 | 357.69M |
March 15, 2024 | 373.12M |
March 14, 2024 | 379.03M |
March 13, 2024 | 390.08M |
March 12, 2024 | 387.77M |
March 11, 2024 | 373.37M |
March 08, 2024 | 391.11M |
March 07, 2024 | 388.03M |
March 06, 2024 | 373.63M |
March 05, 2024 | 390.60M |
March 04, 2024 | 401.65M |
March 01, 2024 | 415.02M |
February 29, 2024 | 416.82M |
February 28, 2024 | 384.43M |
February 27, 2024 | 421.44M |
February 26, 2024 | 421.19M |
February 23, 2024 | 390.34M |
February 22, 2024 | 388.03M |
February 21, 2024 | 398.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
29.23M
Minimum
Oct 14 2022
23.29B
Maximum
Feb 19 2020
2.170B
Average
355.48M
Median
Enterprise Value Benchmarks
Perspective Therapeutics Inc | 990.24M |
Retractable Technologies Inc | -12.89M |
Xtant Medical Holdings Inc | 128.19M |
Asensus Surgical Inc | 43.86M |
Catheter Precision Inc | 0.6003M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -7.065M |
Revenue (Quarterly) | 14.20M |
Total Expenses (Quarterly) | 26.47M |
EPS Diluted (Quarterly) | -0.28 |
Gross Profit Margin (Quarterly) | 87.35% |
Profit Margin (Quarterly) | -49.77% |
Earnings Yield | -15.96% |
Normalized Earnings Yield | -15.96 |